This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

I. Efficacy in Short-term Treatment

Gerald L. Klerman, MD

Arch Gen Psychiatry. 1988;45(5):407-412.

Abstract
• The Cross-National Collaborative Panic Study is a two-phase multinational, multicenter controlled trial for the evaluation of drug treatment of panic disorder and associated agoraphobia. The First Phase compared alprazolam with placebo in a large sample of more than 600 subjects at eight centers—five in the United States, two in Canada, and one in Australia. the Second Phase compared alprazolam, imipramini hydrochioride, placebo in more than 1100 patients in 14 countries. The scientific background, aims and purposes, governance, and policies regarding statistical analyses and scientific presentations and publications are reviewed as background for the series of individual articles reporting detailed findings from the First Phase.

Author Affiliations
From the Department of Psychiatry, Cornell University Medical School, New York.

Footnotes
Accepted for publication Feb 4, 1988.

Reprint requests to the New York Hospital-Cornell Medical Center, Westchester Division, 21 Bloomingdale Rd, White Plains, NY 10605 (Dr Klerman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Shaping the Intimate:: Influences on the Experience of Everyday Nerves
Healy
Social Studies of Science 2004;34:219-245.
ABSTRACT  

Post-traumatic stress and disability
Neal et al.
Br. J. Psychiatry 2004;184:247-250.
ABSTRACT | FULL TEXT  

Cognitive-Behavioral Treatment of Panic Attacks
McClanahan and Antonuccio
Clinical Case Studies 2002;1:211-223.
ABSTRACT  

Academic Medical Center/Industry Collaboration
DeVeaugh-Geiss
Arch Gen Psychiatry 1991;48:754-756.
ABSTRACT  

Quality of Life in Panic Disorder
Markowitz et al.
Arch Gen Psychiatry 1989;46:984-992.
ABSTRACT  

The 'Efficacy' of Alprazolam in Panic Disorder and Agoraphobia: A Critique of Recent Reports
Marks et al.
Arch Gen Psychiatry 1989;46:668-670.
ABSTRACT  

Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: I. Efficacy in Short-term Treatment
Ballenger et al.
Arch Gen Psychiatry 1988;45:413-422.
ABSTRACT